ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Wednesday

ClearPoint Neuro (NASDAQ:CLPT - Get Free Report) is expected to be releasing its earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $8.23 million for the quarter. Investors interested in registering for the company's conference call can do so using this link.

ClearPoint Neuro Stock Performance

CLPT traded down $0.73 during trading on Friday, reaching $16.72. 191,341 shares of the stock were exchanged, compared to its average volume of 201,089. The stock has a market cap of $461.22 million, a P/E ratio of -24.23 and a beta of 1.03. The stock's 50 day moving average price is $16.58 and its two-hundred day moving average price is $13.50. ClearPoint Neuro has a twelve month low of $5.11 and a twelve month high of $19.22.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CLPT. B. Riley upped their target price on ClearPoint Neuro from $15.00 to $20.00 and gave the company a "buy" rating in a research report on Tuesday, January 28th. Lake Street Capital upped their price target on ClearPoint Neuro from $17.00 to $30.00 and gave the company a "buy" rating in a research report on Tuesday, January 21st.

ClearPoint Neuro Company Profile

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.